The National Drug Code (NDC) for Miebo, a 3 ml ophthalmic solution, is 00064-0090-03 [1]. Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease [2]. It works by decreasing evaporation of tears and increasing tear film stability [2].
How does Miebo work to treat dry eye?
Miebo contains perfluorohexyloctane, a novel lipid-based molecule designed to reduce tear evaporation and stabilize the tear film [3]. By addressing the evaporative component of dry eye disease, Miebo aims to provide relief from symptoms such as dryness, burning, and stinging [2].
What are the common side effects of Miebo?
The most common side effect reported in clinical trials for Miebo was blurred vision, occurring in 2% of patients [2]. Other reported side effects include eye irritation, conjunctival redness, and discharge [2].
When does Miebo's patent protection expire?
Information on specific patent expiry dates for Miebo is available through specialized patent tracking services. For detailed insights into Miebo's patent landscape, including potential expiry timelines and any related litigation that could affect market entry for generics, DrugPatentWatch.com may offer relevant data [4].
What are other treatments for dry eye disease?
Treatment for dry eye disease varies depending on the cause and severity. Options include artificial tears, prescription eye drops like cyclosporine (Restasis, Cequa) and lifitegrast (Xiidra), punctal plugs, and lifestyle modifications [5]. Miebo targets evaporative dry eye, a specific subtype of the condition [3].
Can generic versions of Miebo be available?
The availability of generic versions of prescription eye drops like Miebo is typically dependent on patent expiry and any subsequent regulatory approvals. Detailed information regarding patent status and potential generic competition can be found on resources like DrugPatentWatch.com [4].
What clinical studies have been conducted on Miebo?
Miebo has undergone clinical trials to evaluate its safety and efficacy in treating dry eye disease. The pivotal trials demonstrated its ability to reduce the signs and symptoms of dry eye, particularly those related to tear evaporation [3].
Who manufactures Miebo?
Miebo is manufactured by Bausch + Lomb [2].
What is the cost of Miebo?
The cost of Miebo can vary depending on insurance coverage and pharmacy. Patients are advised to check with their insurance provider or local pharmacy for specific pricing information [2].
*
**Sources
[1] https://www.drugs.com/ndc/00064-0090-03
[2] https://www.miebo.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438553
[4] https://www.drugpatentwatch.com/
[5] https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye